Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Peanut Hypersensitivity

• Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
• Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
• Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts
• Phase 1b/2a of CNP-201 in Subjects With Peanut Allergy
• Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy
• Preventing Anaphylaxis With Acalabrutinib
• Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy
• Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy
• Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
• Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
• A Phase 1 Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut.
• Food Oral Immunotherapy for Peanut Allergy
• Oral Immunotherapy for Peanut Allergic Patients
• Boiled Peanut Oral Immunotherapy
• Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
• Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
• A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein D
• Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
• Clinical Study Using Biologics to Improve Multi OIT Outcomes
• A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
• Salvage Peanut Oral Immunotherapy Study
• Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
• HAL-MPE1 Safety and Tolerability Study
• Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
• A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membra
• High Threshold Peanut Challenge Study
• Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy
• FARE Peanut SLIT and Early Tolerance Induction
• HAL-MPE1 First-in-human
• The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery
• Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers
• Walnut Oral Immunotherapy for Tree Nut Allergy
• The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
• Oral Peanut Immunotherapy for Peanut Allergic Patients
• Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
• Tolerance Following Peanut Oral Immunotherapy
• Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization
• Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy
• Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
• Oral Peanut Immunotherapy
• Xolair Enhances Oral Desensitization in Peanut Allergic Patients
• Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
• A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
• Omalizumab in the Treatment of Peanut Allergy
• Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
• Oral Immunotherapy (OIT) for Peanut Allergy
• A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
• A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g
• A Safety and Efficacy Study of Xolair in Peanut Allergy